Abstract
The significance and burden of antimicrobial resistance (AMR) has been well documented. The 2016 O’Neill report highlighted the enormous risk that AMR poses to human health and made recommendations to address this global challenge [1]. The report prompted the UK’s 20 year vision for AMR [2], highlighting how the UK will contain and control antimicrobial resistance by 2040. Alongside this vision, a 5 year National Action Plan (NAP) [3], 2019–2024, was created; laying out how government departments would deliver co-ordinated action to mitigate the impact of AMR.